MTIP AG
Private equity
Active
Basel, Switzerland
18
20M
13
1.80
5
0.28
1
- Stages of investment
- Areas of investment
Summary
In 2014 was created MTIP AG, which is appeared as VC. The venture was found in Europe in Switzerland. The main office of represented VC is situated in the Basel.
Among the most popular fund investment industries, there are Biotechnology, Robotics. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Lumeon, TytoCare, Cynerio. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel.
The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.
The fund was created by Christoph Kausch, Felix Grisard, Hans Florian Zeilhofer.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the MTIP AG, startups are often financed by Walgreens, Teuza, OrbiMed. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, Bayern Kapital GmbH, Walgreens. In the next rounds fund is usually obtained by TechWald Holding S.p.A., Shenzhen Capital Group, Sanford Health.
Investor highlights
- Geo focus
- Check size
- Up to 55M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 5
- Exits
- 1
- Rounds per year
- 1.80
- Follow on index
- 0.28
- Investments by industry
- Health Care (17)
- Medical Device (8)
- Medical (5)
- Artificial Intelligence (5)
- Hospital (4) Show 24 more
- Investments by region
-
- United Kingdom (4)
- United States (4)
- Spain (2)
- Belgium (1)
- France (1) Show 4 more
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 26M
- Group Appearance index
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Inlaylink | 29 Aug 2006 | Manufacturing, RFID, Satellite Communication | Seed | 309K | Shanghai, China |
NitiNotes | 25 Mar 2020 | Health Care, Medical Device, Medical | Early Stage Venture | 7M | Tel Aviv District, Tel Aviv-Yafo, Israel |
NitiNotes | 25 Sep 2023 | Health Care, Medical Device, Medical | Early Stage Venture | 10M | Tel Aviv District, Tel Aviv-Yafo, Israel |
Oasis Technology | 15 Feb 2000 | Internet, Software, Payments | Early Stage Venture | 25M | Ontario, Old Toronto, Canada |
Testfire Labs | 15 Nov 2017 | Software, Artificial Intelligence, Machine Learning, Intelligent Systems, Natural Language Processing, Meeting Software | Seed | 1M | Canada, Alberta, Edmonton |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.